Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience

被引:7
|
作者
Matassini, M. V. [1 ]
Marini, M. [1 ]
Angelozzi, A. [2 ]
Angelini, L. [1 ]
Shkoza, M. [1 ]
Compagnucci, P. [3 ,4 ,5 ]
Falanga, U. [3 ,4 ,5 ]
Battistoni, I. [1 ]
Pongetti, G. [1 ]
Francioni, M. [1 ]
Piva, T. [6 ]
Mucaj, A. [6 ]
Nicolini, E. [6 ]
Maolo, A. [6 ]
Di Eusanio, M. [7 ]
Munch, C. [8 ]
Dello Russo, A. [3 ,4 ,5 ]
Perna, G. [1 ]
机构
[1] Osped Riuniti Ancona, Cardiovasc Dept, Cardiol Div, Cardiac Intens Care Unit, Ancona, Italy
[2] G Mazzini Hosp, Cardiovasc Dept, Unit Cardiol & Cardiac Intens Therapy, Teramo, Italy
[3] Univ Hosp Osped Riuniti Ancona, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Hosp Osped Riuniti Ancona, Cardiol & Arrhythmol Clin, Ancona, Italy
[5] Marche Polytech Univ, Ancona, Italy
[6] Osped Riuniti Ancona, Cardiovasc Dept, Intervent Cardiol Cardiol Div, Ancona, Italy
[7] Osped Riuniti Ancona, Cardiovasc Dept, Cardiac Surg Unit, Ancona, Italy
[8] Osped Riuniti Ancona, Anaesthesia & Cardiac Surg Intens Care, Ancona, Italy
来源
关键词
heart failure; Impella; weaning; outcomes; complications; cardiogenic shock; MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR SUPPORT; DEVICE; PUMP;
D O I
10.3389/fcvm.2023.1171956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving hemodynamic status of affected patients. Impella devices should be used for the shortest time necessary to allow LV recovery because of time-dependent device-related adverse events. The weaning from Impella, however, is mostly performed in the absence of established guidelines, mainly based on the experience of the individual centres. MethodsThe aim of this single center study was to retrospectively evaluate whether a multiparametrical assessment before and during Impella weaning could predict successful weaning. The primary study outcome was death occurring during Impella weaning and secondary endpoints included assessment of in-hospital outcomes. ResultsOf a total of 45 patients (median age, 60 [51-66] years, 73% male) treated with an Impella device, 37 patients underwent impella weaning/removal and 9 patients (20%) died after the weaning. Non-survivors patients after impella weaning more commonly had a previous history of known heart failure (p = 0.054) and an implanted ICD-CRT (p = 0.01), and were more frequently treated with continuous renal replacement therapy (p = 0.02). In univariable logistic regression analysis, lactates variation (%) during the first 12-24 h of weaning, lactate value after 24 h of weaning, left ventricular ejection fraction (LVEF) at the beginning of weaning, and inotropic score after 24 h from weaning beginning were associated with death. Stepwise multivariable logistic regression identified LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning beginning as the most accurate predictors of death after weaning. The ROC analysis indicated 80% accuracy (95% confidence interval = 64%-96%) using the two variables in combination to predict death after weaning from Impella. ConclusionsThis single-center experience on Impella weaning in CS showed that two easily accessible parameters as LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning begin were the most accurate predictors of death after weaning.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] PREDICTORS OF COVID-19 OUTCOMES: A SINGLE-CENTER EXPERIENCE
    Dhaliwal, Lovekirat
    Khan, Mohammad
    Vyas, Aditya
    Boparai, Sukhmani
    Rehmani, Muhammed
    Shah, Pooja
    Husain, Kabir
    Bawa, Danish
    Khalid, Aqsa
    Gandu, Siva Santosh
    Krishnan, Prathik
    Papayannis, Ioannis
    Kulkarni, Shreedhar
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 60 - 60
  • [22] Mono-center experience in safety and efficacy of the Impella device in cardiogenic shock
    Richter, A.
    Traser, J.
    Karatolios, K.
    Luesebrink, U.
    Schoppet, M.
    Schieffer, B.
    EUROPEAN HEART JOURNAL, 2014, 35 : 353 - 353
  • [23] Impella for cardiogenic shock : a tertiary care center experience (2011-2017)
    Seguy, Benjamin
    Gerbaud, Edouard
    Cetran, Laura
    Casassus, Frederic
    Coste, Pierre
    Ouattara, Alexandre
    Barandon, Laurent
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B301 - B302
  • [24] Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock
    Sugimura, Yukiharu
    Immohr, Moritz Benjamin
    Mehdiani, Arash
    Boeken, Udo
    Aubin, Hug
    Lichtenberg, Artur
    Akhyari, Payam
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 30 (01)
  • [25] Outcomes With Impella 5.0 And 5.5 In Cardiogenic Shock
    Tonleu, Franck H. Azobou
    Zapata, David
    Daneshmand, Mani
    Staloch, Dustin
    Agrawal, Akanksha
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S72 - S72
  • [26] Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices
    Hetzer, Roland
    Potapov, Evgenij V.
    Alexi-Meskishvili, Vladimir
    Weng, Yuguo
    Miera, Oliver
    Berger, Felix
    Hennig, Ewald
    Huebler, Michael
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 141 (03): : 616 - U296
  • [27] Use of the Impella 5.0 Micro-Axial Flow Device in Refractory Cardiogenic Shock - A Single Center Experience
    Taimeh, Ziad
    Simpson, Leo
    George, Joggy
    Ynalvez, Leslie Ammabel
    Sudhakar, Deepthi
    Hong Loan Nguyen
    Nair, Ajith
    Oberton, Selby
    Delgado, Reynolds, III
    Seth, Samar
    Bandeali, Salman
    Morgan, Jeffrey
    Loor, Gabriel
    Shafii, Alexis
    Liao, Kenneth
    Civitello, Andrew
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S188 - S189
  • [28] Single center experience and early outcomes of Impella 5.5
    Funamoto, Masaki
    Kunavarapu, Chandra
    Kwan, Michael D.
    Matsuzaki, Yuichi
    Shah, Mahek
    Ono, Masahiro
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [29] MANAGEMENT OF SEVERE CARDIOGENIC SHOCK WITH THE IMPELLA MICROAXIAL LEFT VENTRICULAR ASSIST DEVICE: EARLY EXPERIENCE IN A SINGLE CENTER
    Mazine, A.
    Forcillo, J.
    Demers, P.
    Bouchard, D.
    Lamarche, Y.
    Carrier, M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S226 - S226
  • [30] International cooperation in cardiogenic shock is key to improving outcomes: Cardiogenic Shock Working Group impacts a single-center in a developing country
    Ortega-Hernandez, J. A.
    Gonzalez-Pacheco, H.
    Hernandez-Montfort, J.
    Manzur-Sandoval, D.
    Gopar-Nieto, R.
    Sierra-Lara-Martinez, D.
    Araiza-Garaygordobil, D.
    Kanwar, M.
    Sinha, S. S.
    Garan, A. R.
    Burkhoff, D.
    Kapur, N.
    Arias-Mendoza, A.
    EUROPEAN HEART JOURNAL, 2024, 45